To report a case of retinal vasoproliferative tumor (VPT) with secondary epiretinal membrane (ERM) formation and vitreo-macular traction managed by pars plana vitrectomy (PPV) and membrane peel. A 29-year-old male was referred for management of decreased vision in the right eye (OD) for 1 week. Presenting visual acuity was 20/50 Snellen feet (ft) OD, and fundus examination showed an ERM associated with a reddish-yellow mass in the inferotemporal quadrant with overlying exudation, hemorrhage, and subretinal fluid consistent with VPT, and cryotherapy was recommended. Two months later, there was complete tumor regression, but there was decreased vision from progressive vitreomacular traction to 20/400 ft. PPV with combined ERM and internal limiting membrane (ILM) peel were performed with resolution of vitreomacular traction and improvement of visual acuity to 20/50 ft at 6 months. PPV with combined ERM and ILM peel is effective for vision loss secondary to ERM and vitreomacular traction associated with retinal VPT.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084501PMC
http://dx.doi.org/10.4103/0974-620X.192280DOI Listing

Publication Analysis

Top Keywords

vitreomacular traction
16
pars plana
8
plana vitrectomy
8
membrane peel
8
traction associated
8
associated retinal
8
retinal vasoproliferative
8
decreased vision
8
visual acuity
8
acuity 20/50
8

Similar Publications

Purpose: To evaluate the potency and security of Pneumatic Vitreolysis (PVL) as the primary treatment for Full-Thickness Macular Holes (FTMHs) and provide insights into patient selection criteria and procedural outcomes.

Patients And Methods: A retrospective analysis of three clinical cases presenting with FTMHs treated initially with PVL was conducted. Cases were evaluated for anatomical and functional outcomes through comprehensive ophthalmic examination and optical coherence tomography (OCT) imaging.

View Article and Find Full Text PDF
Article Synopsis
  • A 70-year-old woman was diagnosed with stellate nonhereditary idiopathic foveomacular retinoschisis, showing schisis cavities in the outer plexiform layer of her left eye through optical coherence tomography.
  • No leakage was observed in fluorescein angiography, and other potential causes for her condition were ruled out.
  • After five years, her visual acuity remained stable, the retinoschisis in her left eye resolved, but new cystoid spaces developed in the right eye, highlighting the need for multimodal imaging for monitoring such conditions.
View Article and Find Full Text PDF

Purpose: This study investigated the clinical features and surgical outcomes of full-thickness macular holes (FTMHs) without focal vitreomacular traction (VMT) and discusses possible underlying mechanisms.

Methods: This was a retrospective observational study included patients aged 18 years or older with stage 2 FTMHs who underwent pars plana vitrectomy at three hospitals between December 2016 and March 2024. Patients diagnosed without focal VMT in the macula were classified as VMT- and those with focal VMT were classified as VMT+.

View Article and Find Full Text PDF

Presumed phototoxicity from macular vital staining with Brilliant Blue G and Trypan Blue: A post-market surveillance study, systematic review, and synthesis of the literature.

Surv Ophthalmol

November 2024

King's Ophthalmology Research Unit (KORU), King's College Hospital, London, United Kingdom; Faculty of Life Sciences and Medicine, King's College London, United Kingdom.

Article Synopsis
  • * A study identified 69 cases of dye-related phototoxicity, mostly linked to vitrectomies for macular issues, although quantifying the risk is complicated due to possible bias in reporting.
  • * Risk factors include longer surgeries and multiple dye applications, with consequences like changes in retinal pigmentation and poorer final visual acuity compared to pre-surgery levels; a new reporting template aims to standardize toxicity data.
View Article and Find Full Text PDF

Purpose: To investigate the effect of vitreomacular traction (VMT) on vitreous vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) levels in patients with active neovascular age-related macular degeneration (nAMD).

Design: A prospective, interventional, case-control study.

Methods: The study included a total of 70 patients from whom vitreous samples were obtained.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!